We are live on ! Find out more
PC

Paulson & Co Portfolio holdings

AUM $3.11B
1-Year Est. Return 94.93%
This Fund
S&P 500
This Quarter Est. Return
+3.71%
1 Year Est. Return
+94.93%
3 Year Est. Return
+233.32%
5 Year Est. Return
+258.51%
10 Year Est. Return
+934.97%
AUM
$3.11B
AUM Growth
-$150M
Cap. Flow
-$127M
Cap. Flow %
-4.09%
Top 10 Hldgs %
100%
Holding
10
New
1
Increased
2
Reduced
1
Closed
1

Top Buys

Rank Stock Value
1
THM
International Tower Hill Mines
THM
+$74.8M
2
THRY icon
Thryv Holdings
THRY
+$16.1M
3
FOLD
Amicus Therapeutics
FOLD
+$464K

Top Sells

Rank Stock Value
1
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$151M
2
SOLS
Solstice Advanced Materials
SOLS
+$67.8M

Sector Composition

Rank Sector Weight
1 Materials 49.56%
2 Healthcare 36.15%
3 Financials 13.54%
4 Technology 0.74%

No holdings matched the selected filter criteria.

Similar funds

TCG
Tremblant Capital Group West Palm Beach, Florida $3.11B AUM 18.12% 1-Year Est. Return
CCI
Cevian Capital II St. Helier, Jersey $3.12B AUM 25.62% 1-Year Est. Return
KF
Krilogy Financial St. Louis, Missouri $3.11B AUM 20.67% 1-Year Est. Return
AWM
Axxcess Wealth Management Carlsbad, California $3.12B AUM 21% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.12B AUM 12.93% 1-Year Est. Return
EAM
EULAV Asset Management Sarasota, Florida $3.12B AUM 13.38% 1-Year Est. Return
LFG
Larson Financial Group St Louis, Missouri $3.13B AUM 22.88% 1-Year Est. Return
DCM
Donaldson Capital Management Evansville, Indiana $3.09B AUM 21.24% 1-Year Est. Return

Paulson & Co's Q1 2026 Portfolio in Review

As of Q1 2026, Paulson & Co held 10 positions worth $3.11B, down 4.6% from $3.26B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Paulson & Co withdrew a net $127M in Q1 2026, closing 1 position and reducing 1 holding. Its most notable exit was Solstice Advanced Materials, an estimated $67.8M position sold in full.

By sector, the portfolio is most concentrated in Materials at 50% of assets, up from 42% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Paulson & Co opened a new position in Amicus Therapeutics worth $469K.

  • Paulson & Co's largest Q1 2026 buy was Amicus Therapeutics: 32,400 shares worth $469K.
  • Paulson & Co added most to International Tower Hill Mines in Q1 2026, an estimated $74.8M increase.
  • Paulson & Co's biggest Q1 2026 reduction was Madrigal Pharmaceuticals, cutting an estimated $151M.
  • Paulson & Co fully exited Solstice Advanced Materials in Q1 2026, selling an estimated $67.8M.
  • Paulson & Co's ten largest holdings make up 100% of its $3.11B portfolio in Q1 2026.
  • Paulson & Co opened 1 new position and closed 1 in Q1 2026.
  • Paulson & Co's portfolio value fell 4.6% quarter-over-quarter to $3.11B.

Based on Paulson & Co's 13F filing for Q1 2026, filed 15 May 2026.